secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0000950170-24-087900
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q2 prelim revenue $63.7M (+5% YoY), goodwill impairment $363.6M; CRO resigns
--------------------------------------------------------------------------------

- Revenue $63.7M (+5% YoY); adjusted EBITDA $20.9M (33% margin) vs $17.2M (28%) YoY.
- Net loss $(306.2)M ($(1.81)/share) includes $363.6M goodwill impairment; adjusted net income $0.09/share.
- FY2024 guidance: revenue $247-251M, adjusted EBITDA $74-77M (30-31% margin), adjusted EPS $0.32-0.34.
- CRO Carrie Lazorchak resigns effective Aug 2, 2024; sales organization reports to CEO Kevin Coop.
- Adjusted operating income $19.3M vs $16.0M YoY, up 20.5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024087900/0000950170-24-087900-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017024087900/dh-20240724.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-087900

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer